A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/06 (2006.01) A61K 38/07 (2006.01) A61K 38/08 (2006.01) A61K 47/48 (2006.01) A61K 49/00 (2006.01) C07K 1/16 (2006.01) C07K 5/08 (2006.01) C07K 5/10 (2006.01) C07K 7/06 (2006.01) C12Q 1/37 (2006.01) G01N 33/68 (2006.01)
Patent
CA 2450316
The compounds of the invention are modified forms of therapeutic agents. A typical prodrug compound of the invention comprises a therapeutic agent, an oligopeptide, a stabilizing group and, optionally, a linker group. The prodrug is cleavable by the CD10 enzyme. Methods of treatment using the prodrug and methods of designing a prodrug are also disclosed.
Les composés selon l'invention sont des formes modifiées d'agents thérapeutiques. Un composé de promédicament type selon l'invention comprend un agent thérapeutique, un oligopeptide, une groupe de stabilisation et, éventuellement, un groupe de liaison. Ce promédicament est clivable par l'enzyme CD10. Sont également décrites des méthodes d'utilisation de ce promédicament et des techniques de conception d'un promédicament.
Bebbington Christopher R.
Cardarelli Pina M.
Gangwar Sanjeev
Nieder Matthew H.
Pan Chin
Fetherstonhaugh & Co.
Medarex Inc.
LandOfFree
Cd10-activated prodrug compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cd10-activated prodrug compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cd10-activated prodrug compounds will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1563769